# OnCo record da-tech-anti-amyloid-mab (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/da-tech-anti-amyloid-mab/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "da-tech-anti-amyloid-mab" ;
  schema:name "Anti-amyloid antibodies"@en ;
  schema:description "Infused antibodies can lower amyloid in early Alzheimer’s disease. They need monitoring for brain swelling or bleeding on MRI."@en ;
  schema:url <https://onco.cc/technologies/da-tech-anti-amyloid-mab/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://www.fda.gov/news-events/press-announcements/fda-converts-novel-alzheimers-disease-treatment-traditional-approval> ;
  onco:tag "dementia-atlas" ;
  onco:sections <https://onco.cc/fronts/da-front-anti-amyloid/> ;
  onco:drugs <https://onco.cc/drugs/da-lecanemab/>, <https://onco.cc/drugs/da-donanemab/>, <https://onco.cc/drugs/da-aducanumab/> .